Phase 3 Thyroid Cancer Trial, Recruiting NCT06791005 Sponsor: Second Affiliated Hospital of Xi'an Jiaotong University Condition: Thyroid Cancer
Back to Thyroid Cancer

Phase 3 Thyroid Cancer Trial, Recruiting

NCT06791005
Recruiting Phase 3

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People whose thyroid cancer was identified before surgery as being smaller than 4 cm in size.
  • People whose post-surgery tissue analysis confirmed that cancer was present in both sides of the thyroid, or that cancer had spread to lymph nodes in the side of the neck.
  • People whose vocal cords were checked and found to be normal within one week before surgery.
  • People who had no previous thyroid surgery and needed to have their entire thyroid removed.
  • People whose blood pressure was stable and well-controlled.
  • People who were fully awake and able to communicate clearly after surgery.

Who may not be able to join:

  • People who received radiation therapy, chemotherapy, or radioactive isotope treatment before joining the trial.
  • People with a history of previous thyroid surgery.
  • People under 16 years of age.
  • People with known allergies to the medicines being studied, or who are unable to tolerate surgery.
  • People whose thyroid tumor extended behind the breastbone (confirm with trial site).
  • People whose surgery revealed that the tumor had grown into the parathyroid glands or the nerve that controls the voice box.
  • People whose post-surgery tissue results showed a type of thyroid cancer called medullary carcinoma or undifferentiated carcinoma.
  • People who developed an abnormal opening between the windpipe and surrounding tissue after surgery.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: 0086+029-13384986500

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 3
Sponsor
Second Affiliated Hospital of Xi'an Jiaotong University
Registry
ClinicalTrials.gov
Start date
1 January 2025
Est. completion
30 June 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

age; Genders; Height; Weight; BMI; Tumor Diameter Size; Tumor Location; Pathological Results; Preoperative Serum Calcium; Preoperative Serum Thyroid Hormone; Preoperative Serum Parathyroid Hormone; Preoperative serum TSH; Preoperative Vocal Cord Movement Problems or Laryngoscopy Result; Carbon Nanoparticles Injection Site; Number of Carbon Nanoparticles Injections; Carbon Nanoparticles Injection Dose; Duration of The Operation; Number of Lymph Node Dissection; Intraoperative Hemorrhage; Thyroid Staining; Lymph node staining; Parathyroid Glands Staining; Nanocarbon Leakage; Duration of Postoper...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov